Genome‐wide cfDNA testing of maternal blood

Abstract excerpt

Measurement of cell-free(cf) DNA in maternal blood has been shown to provide effective prediction of fetal trisomy 21 and, to a lesser extent, of trisomies 18 and 13, both in singleton and in twin pregnancy1, 2. This has led to clinical implementation of the test in several countries, usually in women identified through prior screening by the first-trimester combined test to have a high or moderate risk for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Fetal and Pediatric Neurological Disorders
• Share to Parvovirus B19 Infection Studies
• Share to Prenatal Screening and Diagnostics